Direct Fluorescent Antibody Test Kits Market Forecast, Trend Analysis & Competition Tracking - Global Market Insights 2018 to 2028

Introduction

Direct fluorescent antibody test kits detects the existence of an antigen (particularly a protein on the surface of a bacteria, virus or any other microbe). Chemicals of fluorescent is attached to the constant area of an antibody. The antibody binds to produce a specific and sensitive protein tag, if the antigen is present. The direct fluorescent antibody test kits is generally used to detect rabies virus in animal tissues in which tissues of brain is preferred for testing. Direct fluorescent antibody test kits use a fluorescently labeled mAb which bind and illuminate a target antigen. Direct fluorescent antibody test kits is useful for the quick diagnosis of bacterial diseases. The fluorescent antibodies bind to bacteria on a slide of microscope, which allow detection of the bacteria with the help of fluorescence microscope. Thus, the Direct fluorescent antibody test kits is valuable for visualizing bacteria which are difficult to culture or isolate from sample of patient. Direct fluorescent antibody test kits are very sensitive and specific which is generally used on the microbes that is not easily cultured. Also, direct fluorescent antibody test kits uses various types of fluorescent-labeled antibodies to see numerous cell types in single sample.

Rapid visualization of bacteria from a sample such as a throat swab or sputum is achieved through direct fluorescent antibody test which drive the market of direct fluorescent antibody test kits. Direct fluorescent antibody test kits are quick to use, easy to measure, see and is able to bind to target markers with high specificity which further fuel the of direct fluorescent antibody test kits market. Increasing improved laboratory techniques, growing experimental clinical observations further spur the market of direct fluorescent antibody test kits in near future. Increasing incidence of rabies worldwide is one of the major factor driving the growth of direct fluorescent antibody test kits market in the forecast period.

However, low accuracy associated with the direct fluorescent antibody test kits and negative results obtained by the direct fluorescent antibody test and regulatory scenario regarding the approval for diagnostic tests for bacteria hinder the direct fluorescent antibody test kits market.

Key Manufacturer:

Examples of some of the key manufacturer present in the global direct fluorescent antibody test kits market are Pro Lab Diagnostics Inc, Quidel Corporation, Trinity Biotech Plc., Euroimmun US, Inc., among others.

The report covers exhaustive analysis on,

• Direct Fluorescent Antibody Test Kits Market Segments
• Direct Fluorescent Antibody Test Kits Market Dynamics
• Historical Actual Market Size, 2012 – 2016
• Direct Fluorescent Antibody Test Kits Market Size & Forecast 2016 to 2024
• Direct Fluorescent Antibody Test Kits Market Current Trends/Issues/Challenges
• Competition & Companies involved
• Direct Fluorescent Antibody Test Kits Market Drivers and Restraints

Regional analysis includes

• North America
• Latin America
• Europe
• Asia Pacific Excluding China
• China
• Middle East & Africa

Report Highlights:

• Shifting Industry dynamics
• In-depth market segmentation
• Historical, current and projected industry size Recent industry trends
• Key Competition landscape
• Strategies of key players and product offerings
• Potential and niche segments/regions exhibiting promising growth
• A neutral perspective towards market performance

Segmentation

The global direct fluorescent antibody test kits market is segmented on basis of application, end user and geography.

• Segmentation by Application
  • Rabies Virus Diagnosis
  • Chlamydia Testing
  • Herpes Family Testing
  • Respiratory Family Testing
  • Enterovirus Testing
• Segmentation by End User
  • Hospitals
  • Diagnostic Laboratories
  • Academic Research Institutes
  • Clinical Laboratories

Development of various diagnostic kits ranging from detection to final confirmation of the disease spur the direct fluorescent antibody test kits market. Launch of effective disease control programs to eradicate disease such as Rabies also fuel the direct fluorescent antibody test kits market. Several healthcare organizations engaged in collaboration with healthcare bodies for development of kits and commercialization of novel detection kits boost the direct fluorescent antibody test kits market. According to CDC, in United States, about 40 to 50 thousand people get rabies Post-exposure prophylaxis per year. Furthermore, currently the direct fluorescent antibody test is the only approved test to which confirms rabies in animals. Because of its accuracy and advantages in anatomical-pathological, countries such as U.S., approximately 100,000 suspect animals are tested annually further drive the direct fluorescent antibody test kits market.

The North America is expected to retain its dominance in the direct fluorescent antibody test kits market, owing to development of novel detection assays, growing adoption of new detection kits. Technological advancements and growing awareness are some factor driving the growth of direct fluorescent antibody test kits market in North America. Europe is expected to contribute for the second largest revenue share after North America in the global direct fluorescent antibody test kits market, owing to collaboration of healthcare bodies with the international organization to increase awareness, various campaigns and programs to increase demand of direct fluorescent antibody test kits. Asia Pacific is expected to show rapid growth, due increased incidence of rabies and availability of test kits for the disease diagnosis and rabies prevention and management programs in countries such as India, Japan. Growing healthcare expenditure and adoption of new technological advance test kits is expected to drive the Asia Pacific direct fluorescent antibody test kits market in the forecast period. China is expected to register fast growth, due growing awareness pertaining to the risk of disease by the Department of Public Health and research and development of novel diagnostic techniques. Latin America and Middle East & Africa are projected to exhibit decent growth in direct fluorescent antibody test kits market, due to inadequate healthcare facilities and lack of awareness.